| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 09/06/2006 | EP1698338A2 S-methyl-dihydro-ziprasidone for the treatment of schizophrenia |
| 09/06/2006 | EP1697543A2 Asymmetrically branched polymer conjugates and microarray assays |
| 09/06/2006 | EP1697389A2 Compounds and methods for treating toll-like receptor 2-related diseases and conditions |
| 09/06/2006 | EP1697382A2 Rifamycin analogs and uses thereof |
| 09/06/2006 | EP1696999A2 Adaptive resynchronization therapy system |
| 09/06/2006 | EP1696949A2 Vegf receptor antagonists |
| 09/06/2006 | EP1696918A2 A method of treating hiv infection in atazanavir resistant patients using a combination of atazanavir and another protease inhibitor |
| 09/06/2006 | EP1696898A2 Zn 24 -chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors |
| 09/06/2006 | EP1696882A1 Combined doses of tiotropium and fluticasone |
| 09/06/2006 | EP1696877A2 Methods for treating pain |
| 09/06/2006 | EP1696859A2 Method for improving insulin sensitivity by administering an inhibitor of antitrypsin |
| 09/06/2006 | EP1696857A2 Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal |
| 09/06/2006 | EP1453520B1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
| 09/06/2006 | CN1829727A High viscosity xanthan polymer preparations |
| 09/06/2006 | CN1829711A Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 09/06/2006 | CN1829531A Method of inhibiting tumor growth with anti-tissue factor antibodies |
| 09/06/2006 | CN1829528A Compositions comprising gastrin compounds and their use in diabetes |
| 09/06/2006 | CN1829525A Immunotherapeutics for biodefense |
| 09/06/2006 | CN1829521A Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 09/06/2006 | CN1829509A Combinations of drugs for the treatment of neoplasms |
| 09/06/2006 | CN1829507A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 09/06/2006 | CN1829489A Preoperative treatment of post operative pain |
| 09/06/2006 | CN1829482A Treatment of dependence withdrawal |
| 09/06/2006 | CN1827108A Use of cytosine derivative for preparing drug for treating cancer |
| 09/06/2006 | CN1273130C Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability |
| 09/05/2006 | US7102001 Process for preparing pyrrolotriazine |
| 09/05/2006 | US7101964 Vancomycin derivatives provide enhanced antibacterial activity, selectivity and reduced mammalian toxicity |
| 09/05/2006 | US7101962 Antibodies of the P2Y10 receptor useful in altering T lymphocyte function |
| 09/05/2006 | US7101960 Process for removing bile salts from a patient and alkylated compositions therefor |
| 09/05/2006 | US7101877 Trans-[2-(4-Morpholinyl)-1-(2-Naphthenethoxy)]Cyclohexane Monohydrochloride; selectively inhibiting cardiac early repolarising currents and cardiac sodium currents |
| 09/05/2006 | US7101871 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/05/2006 | US7101861 For therapy and prophylaxis of host infected with flavivirus or pestivirus |
| 09/05/2006 | US7101574 Pharmaceutical composition containing fenofibrate and the preparation method |
| 08/31/2006 | WO2006048862A3 The use of a protease or a protease inhibitor for the manufacture of medicaments |
| 08/31/2006 | WO2005058252A3 Glp-1 pharmaceutical compositions |
| 08/31/2006 | WO2005051318A3 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 08/31/2006 | WO2005041894A3 Compositions and methods for treating, preventing, reversing and inhibiting pain |
| 08/31/2006 | WO2005032455A3 Combinatorially selected phosphorodithioate aptamer targeting ap-1 |
| 08/31/2006 | WO2005030142A3 Rifalazil formulations |
| 08/31/2006 | WO2005016281A3 Diagnosis and treatment of malignant neoplasms |
| 08/31/2006 | WO2004087053A3 Dipeptidyl peptidase inhibitors |
| 08/31/2006 | US20060195067 Delivery of immune response modifier compounds |
| 08/31/2006 | US20060194951 Polynucleotides encoding interferon gamma polypeptides |
| 08/31/2006 | US20060194866 Less toxicity; side effects redution; substituted p-chlorobenzene and a pyrrolethoxybenzene |
| 08/31/2006 | US20060194840 Method for treating snoring and sleep apnea with leukotriene antagonists |
| 08/31/2006 | US20060194815 Methods and compositions for modulating serum cortisol levels |
| 08/31/2006 | US20060194807 Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 08/31/2006 | US20060194804 Hiv replication inhibiting pyrimidines and triazines |
| 08/31/2006 | US20060194783 Cgrp receptor antagonists |
| 08/31/2006 | US20060194776 Compositions and methods for treating tissue ischemia |
| 08/31/2006 | US20060194738 Cytomodulating peptides for treating interstitial cystitis |
| 08/31/2006 | US20060194212 Treatment of AIDS |
| 08/31/2006 | US20060193926 To treat psychiatric and mood disorders, pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders, drug addiction, drug abuse, drug withdrawal, obesity; 2-[1-(3-methoxy-4-pyridin-2-ylphenyl)-1H-pyrrol-3-yl]pyridine; minimal side effects |
| 08/31/2006 | US20060193905 Direct cellular energy delivery system |
| 08/31/2006 | US20060193826 Methods to mobilize progenitor/stem cells |
| 08/31/2006 | US20060193783 Low dose corticosteroid composition |
| 08/31/2006 | US20060193769 Drug releasing biodegradable fiber for delivery of therapeutics |
| 08/30/2006 | EP1695094A2 Disintegratable films for diagnostic devices |
| 08/30/2006 | EP1694825A2 Methods of generating stem cells and embryonic bodies carrying disease-causing mutations and methods of using same for studying genetic disorders |
| 08/30/2006 | EP1694683A2 Synthetic process |
| 08/30/2006 | EP1694364A2 System for treating and preventing breast cancer |
| 08/30/2006 | EP1694347A2 Glycopegylated erythropoietin |
| 08/30/2006 | EP1694330A2 Vinorelbine derivatives |
| 08/30/2006 | EP1694329A2 Diamine and iminodiacetic acid hydroxamic acid derivates |
| 08/30/2006 | EP1694328A2 Methods and compositions for the treatment and management of hemoglobinopathy and anemia |
| 08/30/2006 | EP1694327A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/30/2006 | EP1694325A2 Method of preventing survival of retrovirally cells and of inhibiting formation of infectious retroviruses |
| 08/30/2006 | EP1694315A2 Glycopegylated factor ix |
| 08/30/2006 | EP1694311A2 Chewable soft capsules containing ungelatinized starch |
| 08/30/2006 | EP1694300A2 Dosing methods for beta-d-2',3'-dideoxy-2',3' -didehydro-5-fluorocytidine antiviral therapy |
| 08/30/2006 | EP1694278A2 Glp-1 pharmaceutical compositions |
| 08/30/2006 | EP1694277A2 Methods of administering water-soluble prodrugs of propofol for extended sedation |
| 08/30/2006 | EP1694274A2 Glycopegylated granulocyte colony stimulating factor |
| 08/30/2006 | EP1694273A2 Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| 08/30/2006 | EP1694271A2 Fsh glycosylation mutant |
| 08/30/2006 | EP1646328A4 Treatment of dependence withdrawal |
| 08/30/2006 | EP1608407B1 Dispersible formulation of an anti-inflammatory agent |
| 08/30/2006 | EP1551432B1 Argyrolobium roseum plant extracts for treating diabetes |
| 08/30/2006 | EP1066042B1 Steroidal saponins for treating alzheimer's disease |
| 08/30/2006 | CN1826343A Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 08/30/2006 | CN1826334A Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity |
| 08/30/2006 | CN1826333A Diamine derivatives |
| 08/30/2006 | CN1826137A Inducible ligand for alpha1beta1 integrin and uses |
| 08/30/2006 | CN1826117A Orally dissolving films |
| 08/30/2006 | CN1826101A Pharmaceutical formulations |
| 08/30/2006 | CN1824656A Methods and compositions utilizing quinazolinones |
| 08/30/2006 | CN1823749A Sertraline salts and sustained-release dosage forms of sertraline |
| 08/30/2006 | CN1823737A Porous drug matrices and methods of manufacture thereof |
| 08/30/2006 | CN1272319C Process for making amlodipine maleate |
| 08/30/2006 | CN1272031C Use of piper betle leaf extractive for preparing medicament against leishmania |
| 08/30/2006 | CN1272019C Medical composite chitinamine gel |
| 08/30/2006 | CN1271993C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
| 08/29/2006 | US7098193 Useful for the treatment of gastrointestinal conditions |
| 08/29/2006 | US7097844 T helper cell epitopes |
| 08/29/2006 | CA2211874C Carrier particles for use in dry powder inhalers |
| 08/24/2006 | WO2006031795A3 Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease |
| 08/24/2006 | WO2005077319A3 Hair treatment compositions comprising a protein disulfide isomerase |
| 08/24/2006 | WO2005041895A8 Albumin binding sites for evaluating drug interactions and methods of evaluating or designing drugs based on their albumin binding properties |
| 08/24/2006 | WO2005030134A3 Relationship of a specific metabolite to insulin resistance |
| 08/24/2006 | WO2005018540A3 Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants |